7-64348792-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001170905.3(ZNF736):āc.929A>Cā(p.Asp310Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000643 in 1,586,744 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001170905.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF736 | NM_001170905.3 | c.929A>C | p.Asp310Ala | missense_variant | 4/4 | ENST00000423484.3 | NP_001164376.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF736 | ENST00000423484.3 | c.929A>C | p.Asp310Ala | missense_variant | 4/4 | 2 | NM_001170905.3 | ENSP00000400852.1 | ||
ZNF736 | ENST00000355095.8 | c.929A>C | p.Asp310Ala | missense_variant | 5/5 | 5 | ENSP00000347210.4 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152146Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000930 AC: 19AN: 204250Hom.: 0 AF XY: 0.000145 AC XY: 16AN XY: 110012
GnomAD4 exome AF: 0.0000655 AC: 94AN: 1434480Hom.: 0 Cov.: 32 AF XY: 0.0000900 AC XY: 64AN XY: 711470
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152264Hom.: 0 Cov.: 33 AF XY: 0.0000940 AC XY: 7AN XY: 74442
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 11, 2024 | The c.929A>C (p.D310A) alteration is located in exon 5 (coding exon 4) of the ZNF736 gene. This alteration results from a A to C substitution at nucleotide position 929, causing the aspartic acid (D) at amino acid position 310 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at